Veradigm | MDRX - Net Income

Stock Price
4.31
Daily Change
-0.19 -4.22%
Monthly
-6.30%
Yearly
-15.49%
Q1 Forecast
7.75

Veradigm reported $14.53M in Net Income for its fiscal quarter ending in September of 2022.





Net Income Change Date
Alcidion AUD 2.54M 3.43M Jun/2025
Ambu A/S DKK 118M 3M Dec/2025
Amplifon EUR 6.3M 28.94M Sep/2025
Cardinal Health USD 467M 17M Dec/2025
Centene USD -1.1B 5.53B Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Cigna USD 1.23B 55.22B Dec/2025
Computer Programs Systems USD -9.81M 4.76M Sep/2024
Convatec Group USD 111.9M 72.6M Dec/2024
CVS Health USD 2.94B 6.92B Dec/2025
Diasorin EUR 38.26M 9.14M Sep/2025
Elevance Health USD 547M 642M Dec/2025
General Electric Aerospace USD 2.54B 384M Dec/2025
Gulf Medical Proj AED 34.98M 12.51M Jun/2025
Humana USD -796M 991M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Maximus USD 75.29M 30.69M Sep/2025
McKesson USD 1.19B 76M Dec/2025
Med Life RON 7.24M 23.18M Sep/2025
Molina Healthcare USD -160M 239M Dec/2025
Omnicell USD -2.03M 7.49M Dec/2025
Oriola-kd EUR 1.7M 7.3M Sep/2025
Owens Minor USD -24.98M 271.13M Mar/2025
Quest Diagnostics USD 245M 0 Dec/2025
Rede D'or Sao Luiz BRL 1.47B 472.3M Sep/2025
Siemens Healthineers EUR 449M 139M Dec/2025
Sonova Holding CHF 188.5M 143.4M Dec/2025
Supermax Corporation Bhd MYR -134.61M 67.57M Sep/2025
UnitedHealth USD 10M 2.34B Dec/2025
Veeva Systems USD 200.31M 27.88M Jun/2025
Veradigm USD 14.53M 78.55M Sep/2022
Xerox USD -109M 19M Jun/2025